<DOC>
	<DOCNO>NCT00703768</DOCNO>
	<brief_summary>The purpose study evaluate difference quality life ( measure FACT-P ) patient treat androgen deprivation therapy ( ADT ) biochemical failure ( PSA recurrence ) follow surgery radiation prostate cancer depend ADT initiate .</brief_summary>
	<brief_title>Quality Life Subjects Receiving Androgen Deprivation Therapy Have Doubling PSA Either Less Than Greater Than 1 Year</brief_title>
	<detailed_description />
	<mesh_term>Androgens</mesh_term>
	<criteria>18 year old Received therapy curative intent ( surgery radiotherapy ) Have rise PSA double nadir value . Histologically proven prostate cancer require androgen deprivation therapy least 12 month Written inform consent participate trial . Known hypersensitivity Zoladex , Casodex , ar component product Prior treatment LHRH agonist antiandrogens past 12 month Any concomitant condition would make undesirable , physician 's opinion , subject participate trial would jeopardize compliance protocol .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>Quality Life</keyword>
	<keyword>Androgen Deprivation Therapy</keyword>
	<keyword>Goserelin</keyword>
</DOC>